v3.25.4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Schedule of Concentrations of Credit Risk and Significant Customers

The following table summarizes customers that represent 10% or greater of our consolidated total gross revenues:

			Years Ended December 31,
			2025						2024						2023
Distributor A			45		%				29		%				28		%
Roche			*						*						15		%
Regeneron Pharmaceuticals			*						11		%				*

__________________________________________

*Represents less than 10% and/or not a customer in the applicable year

The following table summarizes customers with amounts due that represent 10% or greater of our consolidated gross accounts receivable balance:

			As of December 31,
			2025						2024
Distributor A			45		%				16		%
Novartis AG			*						23		%

Schedule of Estimated Useful Lives of Property, Plant and Equipment

The estimated useful lives of property, plant and equipment are as follows:

Asset Category						Useful Life
Laboratory equipment						5 years
Computer equipment and software						3-10 years
Furniture and fixtures						5 years
Leasehold improvements						Shorter of asset life or lease term
Manufacturing equipment						7-15 years
Buildings						40 years

Schedule of Reported Quarterly Amounts and Adjusted Amounts After Applying New Guidance

The following is a summary of the unaudited prior quarterly results for the condensed consolidated statements of operations and comprehensive income (loss) reflecting the previously reported quarterly amounts and adjusted amounts after applying the new guidance of ASU 2025-07.

(In thousands, except per share amounts)			Previously Reported Three Months Ended March 31, 2025						Adjusted Three Months Ended March 31, 2025						Previously Reported Six Months Ended June 30, 2025						Adjusted Six Months Ended June 30, 2025						Previously Reported Nine Months Ended September 30, 2025						Adjusted Nine Months Ended September 30, 2025
Interest expense			$	(38,646)					$	(58,309)					$	(78,892)					$	(119,765)					$	(123,290)					$	(187,227)
Other (expense) income, net			(49,700)						9,191						(56,099)						18,051						(130,249)						8,564
Total other expense, net			(59,673)						(20,445)						(78,832)						(45,555)						(207,845)						(132,969)
(Loss) income before income taxes			(41,596)						(2,368)						(76,954)						(43,677)						162,015						236,891
Net (loss) income			(57,479)						(18,251)						(123,756)						(90,479)						127,328						202,204
Net (loss) income per common share - basic			(0.44)						(0.14)						(0.95)						(0.70)						0.98						1.55
Net (loss) income per common share - diluted			(0.44)						(0.14)						(0.95)						(0.70)						0.95						1.51
Comprehensive (loss) income			$	(60,478)					$	(21,250)					$	(119,190)					$	(85,913)					$	140,071					$	214,947

X

- Definition

Schedule of estimated useful lives of property, plant and equipment.

+ References

No definition available.

+ Details

Name:	alny_ScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTableTextBlock
Namespace Prefix:	alny_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482989/270-10-45-12

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482989/270-10-45-13

+ Details

Name:	us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

+ Details

Name:	us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration